Imaging breast cancer using hyperpolarized carbon-13 MRI
暂无分享,去创建一个
Evis Sala | Fiona J. Gilbert | Martin J. Graves | James Wason | Carlos Caldas | Frank Riemer | Stephan Ursprung | Oscar M. Rueda | Mary A. McLean | James T. Grist | Surrin S. Deen | Fulvio Zaccagna | Ramona Woitek | Charlie J. Daniels | Ilse Patterson | Rhys Slough | Marie-Christine Laurent | Ferdia A. Gallagher | Joshua Kaggie | Elena Provenzano | Titus Lanz | Kevin M. Brindle | Suet-Feung Chin | Turid Torheim | Ian B. Wilkinson | Richard Baird | J. Wason | M. Ross | Z. Kingsbury | F. Zaccagna | S. Chin | C. Caldas | O. Rueda | E. Provenzano | J. Abraham | E. Sala | F. Gilbert | F. Gallagher | M. McLean | A. Patterson | T. Lanz | M. Graves | I. Wilkinson | K. Brindle | T. Torheim | F. Riemer | J. Kaggie | R. Woitek | E. Harrison | R. Baird | D. Lomas | C. Boursnell | Heather Biggs | A. Frary | Zoya Kingsbury | Mark Ross | C. Daniels | A. Gill | Jean E. Abraham | B. Basu | S. Hilborne | A. Chhabra | Bristi Basu | Stephan Ursprung | Heather Biggs | Amy Frary | Andrew B. Gill | Raquel Manzano Garcia | Anita Chhabra | Matthew Locke | Sarah Hilborne | Chris Boursnell | Amy Schiller | Bruno Carmo | Justine Kane | Emma Harrison | Andrew Patterson | David J. Lomas | S. Deen | Raquel Manzano Garcia | J. Grist | R. Slough | J. Kane | M. Locke | Ilse Patterson | Matthew J. Locke | Marie-Christine Laurent | Bruno D Carmo | A. Schiller | Chris Boursnell | Raquel Manzano García | Rhys Slough
[1] Ed Reznik,et al. Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1. , 2020, Cell metabolism.
[2] Y. Chae,et al. Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer , 2019, BMC Cancer.
[3] Christoffer Laustsen,et al. Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology , 2018, Neoplasia.
[4] E. Fertig,et al. Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes , 2018, Molecular Cancer Research.
[5] Joon Jeong,et al. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis , 2018, Breast Cancer Research and Treatment.
[6] F. Gallagher,et al. Analysis of 13C and 14C labeling in pyruvate and lactate in tumor and blood of lymphoma‐bearing mice injected with 13C‐ and 14C‐labeled pyruvate , 2018, NMR in biomedicine.
[7] J. Rahnenführer,et al. Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high‐resolution magic angle spinning 1H NMR spectroscopy , 2018, NMR in biomedicine.
[8] J. Vaidya,et al. Rethinking neoadjuvant chemotherapy for breast cancer , 2018, British Medical Journal.
[9] Ilwoo Park,et al. Development of methods and feasibility of using hyperpolarized carbon‐13 imaging data for evaluating brain metabolism in patient studies , 2018, Magnetic resonance in medicine.
[10] Mike Clarke,et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials , 2018, The Lancet. Oncology.
[11] M. Dugo,et al. Metabolic Footprints and Molecular Subtypes in Breast Cancer , 2017, Disease markers.
[12] Rahul Aggarwal,et al. Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. , 2017, European urology.
[13] Bonnie N. Joe,et al. Imaging Neoadjuvant Therapy Response in Breast Cancer. , 2017, Radiology.
[14] Klaus Fassbender,et al. Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis , 2017, Disease markers.
[15] S. Lunt,et al. Deciphering metabolic rewiring in breast cancer subtypes , 2017, Translational research : the journal of laboratory and clinical medicine.
[16] Elizabeth A Morris,et al. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial , 2017, Journal of magnetic resonance imaging : JMRI.
[17] P. Diest,et al. Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume , 2017, Annals of Surgical Oncology.
[18] S. Fendt,et al. In vivo cancer metabolism is defined by the nutrient microenvironment , 2016 .
[19] P. Larson,et al. Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR. , 2016, Journal of magnetic resonance.
[20] Tess E Wallace,et al. Effect of Radiofrequency Transmit Field Correction on Quantitative Dynamic Contrast-enhanced MR Imaging of the Breast at 3.0 T. , 2016, Radiology.
[21] M. A. van den Bosch,et al. Meta‐analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen , 2016, The British journal of surgery.
[22] S. Horvath,et al. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. , 2016, Cell reports.
[23] Issam Makhoul,et al. Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer , 2016, Breast cancer : basic and clinical research.
[24] Thierry Metens,et al. Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy , 2016, European Radiology.
[25] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[26] Stephanie M. Tortorella,et al. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K , 2015, Molecular Biology Reports.
[27] M. Merritt,et al. Hyperpolarized Magnetic Resonance as a Sensitive Detector of Metabolic Function , 2014, Biochemistry.
[28] Gideon Blumenthal,et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis , 2014, The Lancet.
[29] Y. Mao,et al. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer , 2013, BMC Cancer.
[30] P. Larson,et al. Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.
[31] P. Bolan. Magnetic resonance spectroscopy of the breast: current status. , 2013, Magnetic resonance imaging clinics of North America.
[32] R. Gillies,et al. Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors. , 2013, Cancer research.
[33] W. Jung,et al. Metabolic phenotypes in triple-negative breast cancer , 2013, Tumor Biology.
[34] J. Kurhanewicz,et al. Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. , 2013, Cancer research.
[35] Florian Wiesinger,et al. IDEAL spiral CSI for dynamic metabolic MR imaging of hyperpolarized [1‐13C]pyruvate , 2012, Magnetic resonance in medicine.
[36] K. Brindle,et al. Kinetic Modeling of Hyperpolarized 13C Label Exchange between Pyruvate and Lactate in Tumor Cells* , 2011, The Journal of Biological Chemistry.
[37] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[38] Lucy E. Kershaw,et al. A general dual-bolus approach for quantitative DCE-MRI. , 2011, Magnetic resonance imaging.
[39] F. Gallagher,et al. Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate , 2010, British Journal of Cancer.
[40] Lucio Frydman,et al. Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells , 2009, Proceedings of the National Academy of Sciences.
[41] Albert P. Chen,et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.
[42] S. Paik,et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[44] Guillaume Gilbert,et al. Measurement of signal‐to‐noise ratios in sum‐of‐squares MR images , 2007, Journal of magnetic resonance imaging : JMRI.
[45] Jan Wolber,et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.
[46] M. Thaning,et al. Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[47] T. Eberlein. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer , 2006 .
[48] G. Collins. The next generation. , 2006, Scientific American.
[49] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[50] Michael Molls,et al. Tumor Volume and Tumor Hypoxia in Head and Neck Cancers , 2003, Strahlentherapie und Onkologie.
[51] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[52] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[53] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[54] E. McVeigh,et al. Signal‐to‐noise measurements in magnitude images from NMR phased arrays , 1997 .
[55] M. F. Parry,et al. A Retrospective Analysis , 1990 .
[56] M. Uslenghi,et al. The World Space Observatory (WSO-UV) - Current status , 2008, 0801.2080.